Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Elias U.S.A., Inc. — Predicate Candidate Screening

54 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

118 daysmedian FDA review time
202 days90th percentile
54clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K964385ELIAS ANA-HEP-2Elias U.S.A., Inc.1997-03-061220
K963291VARELISA ANA (4) PROFILEElias U.S.A., Inc.1996-09-30400
K953873VARELISA HELICOBACTER PYLORI ANTIBODIESElias U.S.A., Inc.1996-08-303790
K953587VARELISA MPO-ANCAElias U.S.A., Inc.1996-01-261780
K953586VARELISA PR3-ANCAElias U.S.A., Inc.1996-01-261780
K951187VARELISA CARDIOLIPIN ABS SCREENElias U.S.A., Inc.1995-10-022000
K951205VARELISA ANA PROFILEElias U.S.A., Inc.1995-04-17310
K951206VARELISA PARIETAL CELL ANTIBODIESElias U.S.A., Inc.1995-04-17310
K944334VARELISA COMBINED DNA ANTIBODIES EIAElias U.S.A., Inc.1995-04-172230
K951186VARELISA ANA-4 SCREENElias U.S.A., Inc.1995-04-17320
K951207VARELISA HISTONE ANTIBODIESElias U.S.A., Inc.1995-04-17310
K950031VARELISA DSDNA ANTIBODIES (FARR VERSION)Elias U.S.A., Inc.1995-03-10650
K945607VARELISA M2 ANTIBODIESElias U.S.A., Inc.1995-01-24700
K944171VARELISA CENTROMERE ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944170VARELISA SM ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944173VARELISA JO-1 ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944169VARELISA RO (SS-A) ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944172VARELISA SCL-70 ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944168VARELISA LA (SS-B) ANTIBODIESElias U.S.A., Inc.1994-12-221180
K944167VARELISA RNP-SM ANTIBODIESElias U.S.A., Inc.1994-12-221180
K940403ELIAS CARDIOLIPIN ANTIBODIESElias U.S.A., Inc.1994-09-202360
K940622ELIAS ENA SCREEN (MICROTITER PLATE)Elias U.S.A., Inc.1994-05-111130
K940229SYN ENA SCREEN (PIN PLATE)Elias U.S.A., Inc.1994-05-111130
K940641ELIAS ANA TOTALElias U.S.A., Inc.1994-03-25390
K935468SYNELISA ANA TOTALElias U.S.A., Inc.1994-03-251330
K935469SYNELISA DHEA-SULFATEElias U.S.A., Inc.1994-03-221390
K935288SYNELISA CARDIOLIPIN ANTIBODIESElias U.S.A., Inc.1994-01-24820
K933392ELIAS CARDIOLIPIN IGM ANTIBODIESElias U.S.A., Inc.1993-12-081490
K933393ELIAS CARDIOLIPIN IGG ANTIBODIESElias U.S.A., Inc.1993-12-081490
K932206SYNELISA ANA PROFILEElias U.S.A., Inc.1993-12-032110
K933128SYNELISA PROGESTERONEElias U.S.A., Inc.1993-11-051300
K931177SYNELISA CORTISOLElias U.S.A., Inc.1993-09-272020
K931255SYNELISA CENP-B ANTIBODIESElias U.S.A., Inc.1993-09-241960
K933123SYNELISA TG ANTIBODIES/TPO ANTIBODIESElias U.S.A., Inc.1993-08-23560
K932302SYLNELISA HISTONE ANTIBODIESElias U.S.A., Inc.1993-08-231030
K930422SYNELISA PARIETAL CELL ANTIBODIESElias U.S.A., Inc.1993-08-031890
K930209SYNELISA RO ABS / LA ABSElias U.S.A., Inc.1993-06-111470
K930141SYNELISA SM ABS/RNP-SM ABSElias U.S.A., Inc.1993-05-111190
K930142SYNELISA U1-SNRNP (68KDA)-ANTIBODIESElias U.S.A., Inc.1993-05-111190
K930143AYNELISA M2-ANTIBODIESElias U.S.A., Inc.1993-05-111190
K930281SYNELISA JO-1 ANTIBODIESElias U.S.A., Inc.1993-04-06750
K930417SYNELISA SCL-70 ANTIBODIESElias U.S.A., Inc.1993-04-06700
K930421ELIAS DSDNA ABSElias U.S.A., Inc.1993-03-10430
K925922ELIAS TGABElias U.S.A., Inc.1993-01-14520
K925923ELIAS TMABElias U.S.A., Inc.1993-01-14520
K921132SYN ELISA DSDNA ANTIBODIESElias U.S.A., Inc.1992-12-012660
K924421SYNELISA CARDIOLIPIN ANTIBODIESElias U.S.A., Inc.1992-11-30900
K921787SYNELISA TPO ANTIBODIESElias U.S.A., Inc.1992-07-281050
K921250SYNELISA CARDIOLIPIN ANTIBODIESElias U.S.A., Inc.1992-06-04800
K920132SYN ELISA BETA 2 MICROGLOBULIN TEST KITElias U.S.A., Inc.1992-05-281360

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda